Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination-deficient cancer models. (2021)
Attributed to:
Manipulation of the Complement Pathway to Increase Radiation Sensitivity and Immune Response
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci146256
PubMed Identifier: 34060485
Publication URI: http://europepmc.org/abstract/MED/34060485
Type: Journal Article/Review
Volume: 131
Parent Publication: The Journal of clinical investigation
Issue: 11
ISSN: 0021-9738